I tend to agree..I think the market is very focused on the medical cannabis licence and you will see renewed interest in the stock once received. the underlying business is ticking along very nicely and will provide a solid base of continuing revenue growth.
This article is also very interesting and should help put Elixinol on the map a little more.
https://www.leafly.com/news/industry/investing-in-australias-cannabis-industry-5-companies-to-watch
Ann: Quarterly Report and Appendix 4C, page-13
Add EXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.002(33.3%) |
Mkt cap ! $6.605M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $2.103K | 475.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 7670493 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 924824 | 4 |
View Market Depth
| Last trade - 14.04pm 29/11/2024 (20 minute delay) ? |
| EXL (ASX) Chart |
